NQO1 and COVID-19: Notably, in the context of severe COVID-19, a transcriptomic analysis of lung biopsies from patients revealed the suppression of the NRF2 pathway in response to SARS-CoV-2 infection, marked by the reduced expression of HO-1 and NQO1, which are proteins regulated by NRF2 [48].